Table 4.
Prevalence During Two‐Year NHANES Cyclea | Trend | |||||||
---|---|---|---|---|---|---|---|---|
99–00 | 01–02 | 03–04 | 05–06 | 07–08 | 09–10 | 11–12 | P‐Value | |
Total | 32.2 | 30.6 | 34.8 | 33.3 | 33.6 | 33.4 | 32.6 | 0.39 |
Men | 32.0 | 28.6 | 36.3 | 33.8 | 34.9 | 34.2 | 33.3 | 0.15 |
Women | 32.3 | 32.4 | 33.5 | 32.8 | 32.5 | 32.7 | 32.0 | 0.83 |
Age, y | ||||||||
18–44 | 10.7 | 8.4 | 11.1 | 11.1 | 11.8 | 9.7 | 10.7 | 0.59 |
45–64 | 39.2 | 38.2 | 46.0 | 42.5 | 42.6 | 43.9 | 42.5 | 0.16 |
65–74 | 66.8 | 67.5 | 69.0 | 68.6 | 66.4 | 67.8 | 61.6 | 0.20 |
≥75 | 78.8 | 76.1 | 76.4 | 73.1 | 75.6 | 77.8 | 76.3 | 0.73 |
Race/ethnicity | ||||||||
Non‐Hispanic white | 30.3 | 28.9 | 33.8 | 31.6 | 33.1 | 31.8 | 31.0 | 0.38 |
Non‐Hispanic black | 44.6 | 47.5 | 45.4 | 46.8 | 44.5 | 46.1 | 45.9 | 0.99 |
Hispanicb | 34.4 | 24.7 | 32.4 | 26.5 | 30.9 | 31.3 | 32.1 | 0.64 |
Otherc | 31.7 | 36.2 | 31.9 | 36.2 | 25.2 | 37.5 | 31.0 | 0.85 |
Comorbidities | ||||||||
Obesity | ||||||||
Yes | 44.8 | 40.5 | 46.3 | 43.7 | 43.5 | 45.0 | 43.0 | 0.89 |
No | 26.3 | 25.8 | 29.0 | 27.5 | 28.2 | 26.1 | 26.7 | 0.88 |
Diabetes | ||||||||
Yes | 53.2 | 49.1 | 52.7 | 60.6 | 55.0 | 60.6 | 58.8 | 0.10 |
No | 31.0 | 29.2 | 33.0 | 31.2 | 31.4 | 30.9 | 29.8 | 0.81 |
CKD | ||||||||
Yes | 46.1 | 47.8 | 49.7 | 51.3 | 47.2 | 48.3 | 46.4 | 0.68 |
No | 29.3 | 28.0 | 32.0 | 30.0 | 30.7 | 31.0 | 29.6 | 0.46 |
Number of comorbiditiesd | ||||||||
None | 23.9 | 23.2 | 26.4 | 24.2 | 24.8 | 23.4 | 23.8 | 0.72 |
1 | 38.9 | 36.6 | 40.7 | 37.6 | 39.7 | 39.2 | 36.8 | 0.88 |
2–3 | 58.8 | 55.7 | 58.6 | 62.1 | 53.6 | 63.4 | 60.4 | 0.25 |
Abbreviations: CKD, chronic kidney disease; NHANES, National Health and Nutrition Examination Survey. aUnadjusted prevalence by NHANES cycle. bRepresents just Mexican Americans for 1999–2006 and all Hispanics from 2007–2012. cIncludes non–Mexican American Hispanics from 1999–2006. dComorbidities include obesity, diagnosed diabetes, and CKD.